207 related articles for article (PubMed ID: 37500743)
1. Alterations of gut microbiota in biopsy-proven diabetic nephropathy and a long history of diabetes without kidney damage.
Lu X; Ma J; Li R
Sci Rep; 2023 Jul; 13(1):12150. PubMed ID: 37500743
[TBL] [Abstract][Full Text] [Related]
2. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.
Tao S; Li L; Li L; Liu Y; Ren Q; Shi M; Liu J; Jiang J; Ma H; Huang Z; Xia Z; Pan J; Wei T; Wang Y; Li P; Lan T; Tang X; Zeng X; Lei S; Tang H; Ma L; Fu P
Acta Diabetol; 2019 May; 56(5):581-592. PubMed ID: 30888537
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy.
Zhang L; Wang Z; Zhang X; Zhao L; Chu J; Li H; Sun W; Yang C; Wang H; Dai W; Yan S; Chen X; Xu D
Microbiol Spectr; 2022 Aug; 10(4):e0032422. PubMed ID: 35863004
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota dysbiosis-induced activation of the intrarenal renin-angiotensin system is involved in kidney injuries in rat diabetic nephropathy.
Lu CC; Hu ZB; Wang R; Hong ZH; Lu J; Chen PP; Zhang JX; Li XQ; Yuan BY; Huang SJ; Ruan XZ; Liu BC; Ma KL
Acta Pharmacol Sin; 2020 Aug; 41(8):1111-1118. PubMed ID: 32203081
[TBL] [Abstract][Full Text] [Related]
5. Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury.
Cai K; Ma Y; Cai F; Huang X; Xiao L; Zhong C; Ren P; Luo Q; Chen J; Han F
Endocrine; 2022 May; 76(2):294-303. PubMed ID: 35246764
[TBL] [Abstract][Full Text] [Related]
6. Alteration of gut microbial profile in patients with diabetic nephropathy.
Du X; Liu J; Xue Y; Kong X; Lv C; Li Z; Huang Y; Wang B
Endocrine; 2021 Jul; 73(1):71-84. PubMed ID: 33905112
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the gut virome are associated with type 2 diabetes and diabetic nephropathy.
Fan G; Cao F; Kuang T; Yi H; Zhao C; Wang L; Peng J; Zhuang Z; Xu T; Luo Y; Xie Y; Li H; Zhang K; Zeng Y; Zhang X; Peng S; Qiu X; Zhou D; Liang H; Yang B; Kang J; Liu Y; Zhang Y
Gut Microbes; 2023; 15(1):2226925. PubMed ID: 37349979
[TBL] [Abstract][Full Text] [Related]
8.
Zhou Q; Yang F; Li Z; Qu Q; Zhao C; Liu X; Yang P; Han L; Shi Y; Shi X
J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35617337
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Pathological Characteristics of Patients With Nonproteinuric Diabetic Nephropathy.
Chang DY; Li MR; Yu XJ; Wang SX; Chen M; Zhao MH
Front Endocrinol (Lausanne); 2021; 12():761386. PubMed ID: 34764941
[TBL] [Abstract][Full Text] [Related]
10. The potential role of the gut microbiota in modulating renal function in experimental diabetic nephropathy murine models established in same environment.
Li Y; Su X; Gao Y; Lv C; Gao Z; Liu Y; Wang Y; Li S; Wang Z
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165764. PubMed ID: 32169506
[TBL] [Abstract][Full Text] [Related]
11. [The clinicopathological characteristics of diabetic nephropathy and non-diabetic renal diseases in diabetic patients].
Xu J; Hu XF; Huang W; Shen PY; Zhang W; Ren H; Li X; Wang WM; Chen N; Pan XX
Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):924-929. PubMed ID: 29202533
[No Abstract] [Full Text] [Related]
12. Characteristics of diabetic nephropathy patients without diabetic retinopathy: A retrospective observational study.
Li XQ; Zheng X; Chen M; Zhao MH
Medicine (Baltimore); 2017 May; 96(18):e6805. PubMed ID: 28471980
[TBL] [Abstract][Full Text] [Related]
13. Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota.
Ni Y; Zheng L; Nan S; Ke L; Fu Z; Jin J
Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(10):1406-1420. PubMed ID: 36239349
[TBL] [Abstract][Full Text] [Related]
14. Associations of genetic variants contributing to gut microbiota composition in diabetic nephropathy.
Lu X; Ma J; Guo L; Wu W; Li R
Front Endocrinol (Lausanne); 2023; 14():1264517. PubMed ID: 38189041
[TBL] [Abstract][Full Text] [Related]
15. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
Li L; Zhang X; Li Z; Zhang R; Guo R; Yin Q; Yang L; Yue R; Su B; Huang S; Xu H; He C; Liu F
J Diabetes Complications; 2017 Jan; 31(1):114-121. PubMed ID: 27838100
[TBL] [Abstract][Full Text] [Related]
16. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
[No Abstract] [Full Text] [Related]
17. A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals.
Han S; Chen M; Cheng P; Zhang Z; Lu Y; Xu Y; Wang Y
Front Endocrinol (Lausanne); 2022; 13():1018093. PubMed ID: 36339429
[TBL] [Abstract][Full Text] [Related]
18. Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota.
Deng L; Yang Y; Xu G
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Dec; 1867(12):159234. PubMed ID: 36185030
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus.
Zhuo L; Zou G; Li W; Lu J; Ren W
Eur J Med Res; 2013 Feb; 18(1):4. PubMed ID: 23432977
[TBL] [Abstract][Full Text] [Related]
20. Histological Spectrum of Clinical Kidney Disease in Type 2 Diabetes Mellitus Patients with special Reference to nonalbuminuric Diabetic Nephropathy: A Kidney Biopsy-based Study.
Prakash J; Patel PS; Iqbal M; Sharma SS; Singh S; Agrawal NK; Singh U
J Assoc Physicians India; 2022 Aug; 70(8):11-12. PubMed ID: 36082725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
